Allergic respiratory disease care in the COVID-19 era: A EUFOREA statement

Autor: Anette Drøhse Kjeldsen, Antonella Muraro, Jorge Kleine-Tebbe, Ulrich Wahn, Philippe Gevaert, Andreas Steinsvik, Glenis Scadding, Martin Wagenmann, Ludger Klimek, Peter Hellings, Graham Roberts, Claus Bachert, Zuzana Diamant, Leif Bjermer

Publikováno v: World Allergy Organization Journal
World Allergy Organization journal, 13(5):100124. Lippincott Williams and Wilkins
The World Allergy Organization journal, 13(5):100124. Elsevier
The World Allergy Organization Journal
Scadding, G K, Hellings, P W, Bachert, C, Bjermer, L, Diamant, Z, Gevaert, P, Kjeldsen, A, Kleine-Tebbe, J, Klimek, L, Muraro, A, Roberts, G, Steinsvik, A, Wagenmann, M & Wahn, U 2020, ' Allergic respiratory disease care in the COVID-19 era : A EUFOREA statement ', World Allergy Organization Journal, vol. 13, no. 5, 100124 . https://doi.org/10.1016/j.waojou.2020.100124
WORLD ALLERGY ORGANIZATION JOURNAL

Spring and Summer 2020 are unique in that the challenges of care for those suffering from pollen allergy coincide with the COVID-19 pandemic. Several considerations are important to allow optimal care of allergic rhinitis (AR) and asthma and hence pr

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::cb42056e7d25b7f1897ae7c022d15f33

Efficacy predictors of omalizumab in Chinese patients with moderate-to-severe allergic asthma: Findings from a

Autor: Jing, Li, Changzheng, Wang, Chuntao, Liu, Jian, Kang, Lingfei, Kong, Yijiang, Huang, Shuang, Liu, Mao, Huang, Lu, Wang, Robert, Fogel, Xavier, Jaumont, Jing, Yang, Nanshan, Zhong

Publikováno v: The World Allergy Organization Journal

Background Omalizumab has demonstrated efficacy as an add-on therapy in Chinese patients with moderate-to-severe allergic asthma. This post-hoc analysis assessed the potential predictors for the efficacy of omalizumab in these patients. Methods A pos

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=pmid________::ce729121e2360d54b106f0a865e17511
https://pubmed.ncbi.nlm.nih.gov/34611470

Efficacy predictors of omalizumab in Chinese patients with moderate-to-severe allergic asthma: Findings from a post-hoc analysis of a randomised phase III study.

Autor: Li J; Allergy and Clinical Immunology Department, State Key Laboratory of Respiratory Disease, The First Affiliated Hospital, Guangzhou Medical University, Guangzhou, China., Wang C; Department of Respiratory Disease, Xinqiao Hospital, Third Military Medical University, Chongqing, China., Liu C; Department of Respiratory Disease, West China Hospital, Sichuan University, Sichuan, China., Kang J; Institute of Respiratory Disease, The First Hospital of China Medical University, Shenyang, China., Kong L; Institute of Respiratory Disease, The First Hospital of China Medical University, Shenyang, China., Huang Y; Department of Respiratory Disease, Hainan General Hospital, Hainan Clinical Medicine Research Institution, Hainan, China., Liu S; Department of Respiratory Disease, Beijing Anzhen Hospital, Capital Medical University, Beijing, China., Huang M; Department of Respiratory Disease, The First Affiliated Hospital with Nanjing Medical University, Nanjing, China., Wang L; Beijing Novartis Pharma Co. Ltd., Beijing, China., Fogel R; Novartis Pharmaceuticals Corporation, East Hanover, NJ, USA., Jaumont X; Novartis Pharma AG, Basel, Switzerland., Yang J; Beijing Novartis Pharma Co. Ltd., Beijing, China., Zhong N; Allergy and Clinical Immunology Department, State Key Laboratory of Respiratory Disease, The First Affiliated Hospital, Guangzhou Medical University, Guangzhou, China.

Publikováno v: The World Allergy Organization journal [World Allergy Organ J] 2020 Nov 24; Vol. 13 (12), pp. 100469. Date of Electronic Publication: 2020 Nov 24 (Print Publication: 2020).

Allergic respiratory disease care in the COVID-19 era: A EUFOREA statement.

Autor: Scadding GK; Royal National TNE Hospital and Department of Immunology, University College London, United Kingdom., Hellings PW; University Hospitals Leuven, Department of Otorhinolaryngology-Head and Neck Surgery, Leuven, Belgium.; Upper Airways Research Laboratory and Department of Oto-Rhino-Laryngology, Ghent University, Belgium.; Academic Medical Center, University of Amsterdam, Department of Otorhinolaryngology, Amsterdam, the Netherlands., Bachert C; Upper Airways Research Laboratory and Department of Oto-Rhino-Laryngology, Ghent University, Belgium.; Division of ENT Diseases, CLINTEC, Karolinska Institute, University of Stockholm, Sweden.; First Affiliated Hospital, Sun Yat-sen University, International Airway Research Center, Guangzhou, China., Bjermer L; Department of Respiratory Medicine and Allergology, Skane University Hospital, Lund University, Sweden., Diamant Z; Department of Respiratory Medicine and Allergology, Institute for Clinical Science, Skane University Hospital, Lund University, Lund, Sweden.; Department of Respiratory Medicine, First Faculty of Medicine, Charles University and Thomayer Hospital, Prague, Czech Republic.; Department of Clinical Pharmacy & Pharmacology, University of Groningen, University Medical Center of Groningen and QPS-NL, Groningen, the Netherlands., Gevaert P; Upper Airways Research Laboratory and Department of Oto-Rhino-Laryngology, Ghent University, Belgium., Kjeldsen A; Department of Otorhinolaryngology, Head and Neck Surgery, University of Southern Denmark, Odense, Denmark., Kleine-Tebbe J; Allergy & Asthma Center Westend, Outpatient & Clinical Research Center, Berlin, Germany., Klimek L; Wiesbaden Center for Rhinology and Allergology, Wiesbaden, Germany., Muraro A; Food Allergy Referral Centre Veneto Region, Department of Women and Child Health, Padua General University Hospital, Padua, Italy., Roberts G; David Hide Centre, St Mary's Hospital, Isle of Wight, and University of Southampton, Southampton, United Kingdom., Steinsvik A; Akershus University Hospital, Department of Otorhinolaryngology and Head and Neck surgery, Division of Surgery, Norway., Wagenmann M; Dept. of Otorhinolaryngology, Düsseldorf University Hospital, Germany., Wahn U; Charite, Berlin, Germany.

Publikováno v: The World Allergy Organization journal [World Allergy Organ J] 2020 May 16; Vol. 13 (5), pp. 100124. Date of Electronic Publication: 2020 May 16 (Print Publication: 2020).